- Hong Kong political freedoms in spotlight during bumper trial week
- Debt-saddled Laos struggles to tame rampant inflation
- Senna, Schumacher... Beganovic? Macau GP showcases future F1 stars
- India's vinyl revival finds its groove
- G20 tests Brazil's clout in Lula 3.0 era
- Over 20,000 displaced by gang violence in Haiti: UN agency
- Famed gymastics coach Bela Karolyi dies
- 'Break taboos': Josep Borrell wraps up time as EU's top diplomat
- Climate finance can be hard sell, says aide to banks and PMs
- Trump revives 'peace through strength,' but meaning up to debate
- New York auction records expected for a Magritte... and a banana
- Egypt's middle class cuts costs as IMF-backed reforms take hold
- Beirut businesses struggle to stay afloat under Israeli raids
- Dupont lauds France 'pragmatism' in tight New Zealand win
- Swiatek leads Poland into maiden BJK Cup semi-final
- Trump taps fracking magnate and climate skeptic as energy chief
- West Indies restore pride with high-scoring win over England
- Hull clings to one-shot lead over Korda, Zhang at LPGA Annika
- Xi tells Biden ready for 'smooth transition' to Trump
- Trump nominates fracking magnate and climate skeptic as energy secretary
- Tyson says 'no regrets' over loss for fighting 'one last time'
- Springboks' Erasmus hails 'special' Kolbe after England try double
- France edge out New Zealand in Test thriller
- Xi tells Biden will seek 'smooth transition' in US-China ties
- Netherlands into Nations League quarter-finals as Germany hit seven
- Venezuela to free 225 detained in post-election unrest: source
- Late Guirassy goal boosts Guinea in AFCON qualifying
- Biden arrives for final talks with Xi as Trump return looms
- Dominant Sinner cruises into ATP Finals title decider with Fritz
- Dinosaur skeleton fetches 6 million euros in Paris sale
- Netherlands-Hungary Nations League match interrupted by medical emergency
- Kolbe double as South Africa condemn England to fifth successive defeat
- Kolbe at the double as South Africa condemn England to fresh defeat
- Kolbe at the double as South Africa beat England 29-20
- 'If I don't feel ready, I won't play singles,' says Nadal ahead of Davis Cup farewell
- Fifth of dengue cases due to climate change: researchers
- Trump's Republican allies tread lightly on Paris pact at COP29
- Graham equals record as nine-try Scotland see off tenacious Portugal
- Protesters hold pro-Palestinian march in Rio ahead of G20
- Graham equals record as nine-try Scotland see off dogged Portugal
- China's Xi urges APEC unity in face of 'protectionism'
- Japan's Kagiyama, Yoshida sweep gold in Finland GP
- Macron to press Milei on climate action, multilateralism in Argentina talks
- Fritz reaches ATP Finals title decider with Sampras mark in sight
- All eyes on G20 for breakthrough as COP29 climate talks stall
- Fritz battles past Zverev to reach ATP Finals title decider
- Xi, Biden to meet as Trump return looms
- Kane warns England must protect team culture under new boss
- Italy beat Japan to reach BJK Cup semi-finals
- Farmers target PM Starmer in protest against new UK tax rules
US cracks down on 'tranq' drug linked to fatal overdoses
The United States announced Tuesday a crackdown on unlawful imports of xylazine, an animal tranquilizer known as the "zombie drug" and which is increasingly linked to overdose deaths.
Xylazine, which also goes by the street name "tranq," has recently been found in illicitly manufactured fentanyl, heroin, cocaine and other drugs, presenting a "growing public health concern," the Food and Drug Administration (FDA) said.
"This action aims to prevent the drug from entering the US market for illicit purposes, while maintaining availability for its legitimate uses in animals," it said in a statement.
According to the National Institute on Drug Abuse, the percentage of all drug overdose deaths involving xylazine increased from two percent to 26 percent in the northeast state of Pennsylvania from 2015 to 2020.
Xylazine is typically used by veterinarians to sedate large animals such as horses and deer but the drug is not approved for use in humans.
It can slow breathing, blood pressure and heart rate to critically low levels and cause skin ulcers and abscesses that can lead to amputation.
The FDA said imports of xylazine would be subject to heightened scrutiny and seized if they appear to be unlawful.
"The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part of broader efforts the agency is undertaking to address this issue," FDA commissioner Robert Califf said.
A.O.Scott--AT